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SUMMARY
A recent epidemic of leucomelanoderma in Blacks is
described. A total of 347 patients was seen in two hospitals
during the survey period. The ratio of females to males
was 7:1. A striking pattern af patchy depigmentation and
mottled hypermelanosis occurred predominantly on the
face and neck, but sometimes extended to other areas.
Most but not all cases later showed repigmentation.
The cause of the dyschromia appeared to be mono-
benzone, a bleaching agent recently included in certain
overnight creams packed in wide-mouthed jars.
S. Afr. Med. l., 48, 1555 (1974).
CLINICAL FINDINGS
In recent months (1973/4) many Blacks have attended our
clinics complaining of colour changes in the skin. They
showed a striking leucomelanoderma predominantly
affecting the face, neck and upper chest, although a few
had more extensive involvement. Guttate and larger
patches of partial or complete depigmentation, discrete
or confluent, were found mainly on the forehead, the
eyebrow skin, the sides of the neck, and in males, on the
beard area (Fig. 1). The arms, hands, chest and abdomen
were more rarely involved (Fig. 2). In addition, mottled
areas of hyperpigmentation were often present (Fig. 3).
A preceding mild erythema and irritation had occurred
in some patients, without subsequent scaling. No uniform
history of the ingestion of a drug or a toxic substance
was obtained.
During a 6-month period, 347 cases of leucomelanoderma
were seen, 221 of whom attended Baragwanath Hospital
and 126 the Johannesburg General Hospital. The ratio
of females to males was 7: 1. Many additional cases were
seen outside these survey months. The age incidence of
the condition in patients at Baragwanath Hospital is shown
in Table I.
Initial investigations proved fruitless. No infective agent
could be found, nor any internal metabolic disorder.
Skin biopsies of the lesions showed a normal epidermis
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Fig. 1. Patchy leucodenna is present on the face and
neck.
TABLE I. AGE INCIDENCE OF LEUCOMELANODERMA AT
BARAGWANATH HOSPITAL
Age in years Females Males Total
16 - 20 20 1 21
21 - 30 36 7 43
31 - 40 68 5 73
41 -50 50 12 62
51 - 60 22 0 22
196 25 221
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Fig. 2. Partial depigmentation is widespread over the trunk
and upper arms and patchy on the hands.
w:th som~ incontinence of pigment and a mild inflamma-
tory infiltrat": in th:: upJ:er dermis on histo;ogical
examination.
After a while it became apparent, on repeated direct
questioning, that most of the patients had been applying
a bleaching cream packed in a wide-mouthed glass jar.
Its use was then forbidden and thorough washing advised.
For SClme a topical corticosteroid was prescribed. Most
cases showed repigmentation within the next 2 - 6 months,
often cf conciderable intensity in the earlier stages. As in
vitiligo, the new pigment usually spread out from hair
follicks in a spotty fashion. Sun exposure seemed to
accelerate the process. Some patients have reverted to
normal pigm::ntation, but others are still severely affected
up to 7 mO:1ths after the on,et of the condition. Sites·
such as the hairline area of the brow, the eyebrow skin.
the shaded areas of the neck and unshaved facial skin
were often s;ow to repigment.
It was notable that many patients had use.d the same
brand of overnight cream for years. However, consul-
tat'on with the manufacturers showed that the formula-
Fig. 3. A striking mixture of depigmented, normal and
me:anotic skin is shown here.
tion of the creams had been changed at the end of 1972.
depending upon the pack. Prior to that, ammoniated
mercury, a mild skin-bleaching agent, had commonly
b~en used, despite its ability to produce sensitisation and
postinflammatory hyperpigmentation of the skin in sus-
ceptible subjects. Reports of renal damage following
repeated application to the skin had led to its recent
withdrawal from the market. A more active substitute
now employed is hydroquinone, which has the disadvantage
of being subject to oxidative blackening on exposure to
air. This does not prevent its use in tubes with small
nozzles, but it cannot be dispensed in wide-mouthed
containers. As these jars still enjoy considerable con-
Sllm~r popularity. the monobenzyl ether of hydroquinone.
known as monobenzone. was included in the cream for
this pack in a 2Qo concentration. It was chosen for its
marked skin-bleaching effect and its resistance to oxida-
tion. Salicylic acid was often added in 2% concentration.
The cream was thick and sticky, in order to remain on
the skin ove,night. It transpired that many of our patients
had obtained a jar of the new cream 2 - 4 months before
the onset of the Ieucomelanoderma.
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Experimental patch testing with a patent overnight
cream containing monobenzone 2~~ was carried out by
us in 3 unaffected volunteers. Two 3-cm-square areas a
few cm apart were selected on the back and the cream
applied under occlusion twice daily for 3 - 5 weeks. In one
of the patch areas skin stripping was carried out daily.
Leucoderma occurred in the stripped s;te in I case after
2 weeks (Fig. 4) but the other cases did not depigment
after the limited time of the test.
Fig. 4. Patch testing with a 2% monobenzone cream for
2 weeks has produced leucoderma on the stripped site.
Monobenzone
Monobenzone, or p-benzyloxyphenol monobenzone, is
a whitish, crystalline powder easily soluble in ethanol
and acetone, slightly soluble in liquid paraffin and gly-
cerine, but almost insoluble in water. Being stable, it is a
potent anti-oxidant, and an inexpensive form of it known
as agerite alba has been used for years in the processing
of rubber to prevent perishing. Its ability to bleach skip
was discovered on investigation of an outbreak of leuco-
derma in factory workers wearing rubber gloves.' It has
also proved to be a ready skin sensitiser but can cause
depigmentation independent of this property. Encouraging
reports of its ability to bleach hyperpigmented patches
of skin did appear,' although it was found ineffective in
treating melanomas, cafe-all-lair spots and other pigmented
naevi. Further clinical experience showed that mono-
benzone could cause a disfiguring leucomelanoderma,
both at and distant from the sites of application:"
This was confirmed experimentally when monobenzone
was applied topically in various concentrations to 42
Negro males.' Several weeks of treatment were required
to produce the characteristic dyschromia which was not
always preceded by erythema. The hypopigmentation
commonly extended beyond the area of application and
might appear at unrelated sites. Stopping the treatment
did not necessarily limit the spread of leucoderma and
the first white spot sometimes appeared several months
after the last application. After 4 years one-third of the
affected cases had not repigmented. These findings showed
that monobenzone should be used with great caution as
a therapeutic agent.
Although monobenzone is a strong bleaching agent
clinically, it has no effect in vitro and its exact mode of
action is unknown. It interferes with the biosynthesis of
melanin, preventing the oxidation of tyrosine to phenyl-
alanine. As its effect is not on preformed melanin its
action takes several weeks to become apparent. If the
depigmentary activity of monobenzone were totally
reversible, then its action could be explained solely on the
basis of tyrosinase inhibition' or the tyrosine analogue
effect' or redox properties of a para-substituted phenol
derivative. However, the persistent leucoderma occurring
in some patients could better b:: explained if monoben-
zone acted like topical N-mercapto-ethyl-dimethylamine
which caus~s pigm::nt to disappear and after continuous
use for 2 - 3 months destroys melanocytes,'" implying a
cumulative and eventually cytocidal effect. This lasting cell
injury might be du:: to lipid peroxidation caused by deriva-
t:ves formed by tyrosinase acting on certain phenols, as po~­
tu'ated for other bleaching agents. IO." An antigen-antibody
react:on has b::en suggested" to account for the leuco-
derma found on untreated sites.
DISCUSSION
Altho:.Jgh a definite history of the use of a monobenzone
cream was not found in all patients, it was obtained often
enough to seem significant. The low content of mono-
benzone in the cream was misleading, in that its presence
in undissolved granular form could lead to patchy areas
of highly concentrated chemical cn the skin. Its penetra-
tion through keratin layers was aided by the salicylic
acid. The differing degrees and patterns of dyschromia
seen might also have been due to a cyclic variation in
melanocyte sensitivity." Although many patients have re-
gained a normal skin colour, the fact that some have not
is in accordance with the known permanent effects of
monobenzone.
The cause of the marked degree of melanosis seen
in many cases was not always clear. In some it may
have been a postinflammatory hyperpigmentation, but
preceding erythemJ. was not a feature in all cases. A
photosensitisation effect from one or other constituent of
the cream was another possibility, as occurs with vase-
line." Perhap:; the monobenzone itself is subject to
oxidative darkening, as has been suggested for other
phenols causing exogenous ochronosis."
The distribution of the skin lesions in relation to the
stat::d sites of application of the cream was not easy to
explain. However, the predilection for hairy areas of the
face and neck may have been due to difficulties in
removing the sticky cream. Leucoderma around the np-k
in the collar area, in the armpits and under the waictb3nd
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would seem to conform to patterns of clothing dermatitis
due to chafing by fabric impregnated with bleaching
cream and sweat. Other seemingly unlikely areas of
involvement may have arisen from repeated physical
contact with a partner using the cream or with the
surrounding bedding.
CONCLUSIONS
It seems reasonable to conclude that the recent epidemic
of leucomelanoderma has been caused by the inclusion
of monobenzone in certain bleaching creams. This change
in composition was not always advertised, so the unsus-
pecting individual might well buy fresh supplies of a
preparation used safely in the past. The resultant changes
in skin colour bewildered the user who tended to
continue applying the cream as before. The extended
exposure to monobenzone which resulted was enough to
produce severe and prolonged effects.
The dyschromia in this epidemic can only be described
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as a cosmetic disaster for a dark-skinned individual. It is
suggested that any new bleaching preparation be thorough-
ly tested by clinical trial before its release for general.
use. If a powerful skin-lightener like monobenzone is to
be used at all, it would be better if it were made available
only on prescription.
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